Hal Far, Malta

Malta is our drug product manufacturing site for solid dosage forms.

Main activities

  • GMP commercial manufacturing of solid oral pharmaceutical dosage forms
  • Supply of tablets, film tablets, and hard capsules filled with powder or pellets, in bulk or blister packed
  • cGMP high-potency suite

Features

  • 1 –10 μg / m³ segregated cGMP production areas for high-potency
  • 7 GMP suites: Dry & wet granulation, Tableting (up to 2 billion unit p.a.), Capsuling (up to 1 billion unit p.a.), Coating (up to 1 billion unit p.a.), Blistering (up to 100 million blisters p.a.)

Strategic importance

  • CMO for innovative and generic drug products for the global market
  • Competitive cost structure at Swiss quality level

Facts and Figures

Number of FTE: 125
Production capacity: 7 GMP suites, segregated cGMP production areas for high potency
Competencies: Finished oral dosage forms

Open positions

Address

Siegfried Malta Ltd 
HHF070 Hal Far Industrial Estate 
Hal Far BBG 3000
Malta

Phone +356 2227 7786
info@siegfried-malta.com

Map

Show larger map
to the top to top

Can't find the information
you are looking for?
Contact us

Siegfried AG
Untere Bruehlstrasse 4
CH-4800 Zofingen

Phone: +41 62 746 1111
Fax: +41 62 746 1202
info@siegfried.ch